LungFlag

Research findings: In conjunction with researchers at Roche and the National Taiwan University Hospital and College of Medicine in Taipei, the conclusions of the study demonstrated that LungFlag™ was able to work on Taiwanese EMR data and presented superiority over criteria based selection of individuals (USPSTF) and performed better than gold standard benchmark risk model PLCOm2012 that was adapted to be used on EMR data. The results were comparable to the previous validation studies and indicates that LungFlag™ can immediately support Taiwan screening program in identifying elevated risk populations among ever-smokers and potentially also on never-smokers populations.